Daxxify, Long-lasting Neuromodulator Now Available

Daxxify (DaxibotulinumtoxinA-lanm) is the latest Boxtox® alternative available to patients of Dr. Hamori and Dr. DiEdwardo. The FDA has approved Daxxify for injection for the temporary improvement of moderate to severe frown lines (glabellar lines) in adults. Daxxify is unique as the first and only long-acting neuromodulator stabilized with Peptide Exchange Technology™ (PXT). Based on clinical data, Daxxify has the ability to deliver year-long results with as few as two treatments per year.

To learn if you are a candidate for this injectable, consult with Dr. DiEdwardo or Dr. Hamori, both designated as ExpertInjectors for their training and deep experience with cosmetic injectables.

Christine Hamori Cosmetic Surgery + Skin Spa
113 Tremont Street, Duxbury, Massachusetts, 02332
Call us: 781-934-2200
Serving Boston's South Shore, Cape Cod and Nantucket

Dysport™ Is Here: Competitor to Botox® Now Available

I'm pleased to announce that I am now offering Dysport™ from Medicis (makers of Restylane and Perlane), which is a "botulinum toxin" similar to Botox®. Dysport has been approved by the FDA for the aesthetic indication (glabellar lines) — for the temporary improvement in the appearance of moderate to severe glabellar lines in adults younger than 65 years of age. The active substance in Dysport is a botulinum neurotoxin type A complex. Now I can discuss more options with my patients for treatment of wrinkles and frown lines.

Stay tuned for more information on this new injectable. In the meantime, please see the press release: Medicis Begins Shipping Dysport(TM) for Glabellar Lines.

See related post: Enter Dysport: Here Come the Botox Competitors.